Katherine Vereeke Kuhl, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Katherine Vereeke Kuhl’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A16415 · Cancelled
Licence status: Cancelled · since 1955 · Loma Linda University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$33,092
Medicare paid this office $33,092 for 270 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 68 | $14,054 | $127 |
| Return visit (30+ min) | 89 | $11,424 | $91 |
| Short return visit (20+ min) | 97 | $3,996 | $32 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,165 | $90 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $695 | $58 |
See all 6 services
| Long return visit (40+ min) | 68 | $14,054 | $127 |
| Return visit (30+ min) | 89 | $11,424 | $91 |
| Short return visit (20+ min) | 97 | $3,996 | $32 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,165 | $90 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $695 | $58 |
| Return visit (30+ min) | 14 | $614 | $44 |
Who their Medicare patients are
270 Original Medicare patients in 2024. Average age 77 · Women 52% · Also on Medicaid 10% · Health risk score 2.11. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Cancer 57% · Coronary heart disease 32% · Diabetes 31% · Chronic kidney disease 29% · Atrial fibrillation 27% · Heart failure 21% · COPD 14% · Depression 13% · Stroke 10% · Dementia 4%.
The office billed $177,764, Medicare allowed $45,571 and paid $33,092; for 416 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 270 | 416 | 77 | 2.11 | $177,764 | $33,092 |
| 2023 | 359 | 936 | 78 | 1.97 | $317,864 | $51,869 |
| 2022 | 277 | 839 | 77 | 1.76 | $276,252 | $40,945 |
| 2021 | 196 | 728 | 77 | 2.12 | $216,526 | $39,122 |
| 2020 | 201 | 798 | 78 | 2.34 | $210,298 | $31,289 |
| 2019 | 243 | 943 | 78 | 2.10 | $251,332 | $38,367 |
| 2018 | 429 | 1,542 | 78 | 1.90 | $435,054 | $87,330 |
| 2017 | 364 | 1,183 | 77 | 2.08 | $305,318 | $71,757 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Short return visit (20+ min) | 312 | $39,460 | $51 |
| Telephone medical discussion with physician, 11-20 minutes | 48 | $6,335 | $75 |
| Return visit (30+ min) | 32 | $2,679 | $77 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,589 | $106 |
| Short return visit | 11 | $277 | $25 |
2022: 3 services
| Short return visit (20+ min) | 253 | $35,640 | $48 |
| Telephone medical discussion with physician, 11-20 minutes | 23 | $2,586 | $63 |
| Return visit (30+ min) | 20 | $1,205 | $55 |
2021: 5 services
| Short return visit (20+ min) | 173 | $29,679 | $50 |
| Return visit (30+ min) | 33 | $2,972 | $78 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $2,108 | $75 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,637 | $109 |
| Short return visit | 21 | $919 | $29 |
2020: 4 services
| Short return visit (20+ min) | 179 | $26,336 | $37 |
| Return visit (30+ min) | 20 | $1,251 | $63 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $1,071 | $63 |
| Telephone medical discussion with physician, 5-10 minutes | 17 | $976 | $39 |
2019: 3 services
| Short return visit (20+ min) | 233 | $34,790 | $39 |
| Return visit (30+ min) | 37 | $2,388 | $60 |
| Long return visit (40+ min) | 13 | $1,120 | $86 |
2018: 2 services
| Short return visit (20+ min) | 400 | $78,814 | $55 |
| Return visit (30+ min) | 78 | $7,436 | $81 |
2017: 2 services
| Short return visit (20+ min) | 332 | $64,358 | $59 |
| Return visit (30+ min) | 68 | $6,250 | $86 |
Drugs they prescribed that Part D paid
$2,331,921
Pharmacies billed $2,331,921 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (48 of 935) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
721 generic and 214 brand-name prescriptions · $2,331,921 in drug cost · 35 antibiotic prescriptions to 26 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Imbruvica | 21 | $369,530 | $17,597 |
| Xtandi | 16 | $224,695 | $14,043 |
| Orgovyx | 13 | $34,924 | $2,686 |
| Eliquis | 27 | $29,010 | $1,074 |
| Xarelto | 14 | $16,673 | $1,191 |
See all 22 drugs
| Imbruvica | 21 | $369,530 | $17,597 |
| Xtandi | 16 | $224,695 | $14,043 |
| Orgovyx | 13 | $34,924 | $2,686 |
| Eliquis | 27 | $29,010 | $1,074 |
| Xarelto | 14 | $16,673 | $1,191 |
| Exemestane | 21 | $4,892 | $233 |
| Anastrozole | 56 | $1,161 | $21 |
| Dexamethasone | 35 | $655 | $19 |
| Pantoprazole | 21 | $473 | $23 |
| Gabapentin | 19 | $447 | $24 |
| Potassium Chloride | 12 | $409 | $34 |
| Ondansetron | 40 | $353 | $9 |
| Lorazepam | 32 | $311 | $10 |
| Acyclovir | 15 | $306 | $20 |
| Hydrocodone-Acetaminophen | 13 | $285 | $22 |
| Levothyroxine | 16 | $246 | $15 |
| Tamsulosin | 26 | $246 | $9 |
| Ondansetron Odt | 14 | $151 | $11 |
| Triamcinolone Acetonide | 16 | $151 | $9 |
| Prednisone | 17 | $111 | $7 |
| Metoclopramide | 13 | $75 | $6 |
| Rosuvastatin | 12 | $47 | $4 |
Year by year
| 2024 | 935 | 300 | 5% (48) | 23% | $2,331,921 |
| 2023 | 2,555 | 472 | 8% (197) | 23% | $4,548,810 |
| 2022 | 2,423 | 406 | 9% (217) | 22% | $4,379,394 |
| 2021 | 2,205 | 353 | 11% (232) | 20% | $3,129,608 |
| 2020 | 1,874 | 293 | 13% (243) | 20% | $2,412,968 |
| 2019 | 1,737 | 243 | 14% (234) | None | $1,776,903 |
| 2018 | 1,449 | 202 | 13% (192) | None | $1,017,677 |
| 2017 | 1,238 | 185 | 12% (148) | None | $1,289,162 |
| 2016 | 1,257 | 180 | 15% (188) | None | $1,329,771 |
| 2015 | 983 | 160 | 17% (170) | 17% | $144,707 |
| 2014 | 815 | 132 | 5% (44) | None | $101,749 |
| 2013 | 747 | 130 | 8% (56) | 14% | $106,515 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 67 drugs
| Ibrance | 48 | $709,578 | $14,783 |
| Imbruvica | 34 | $535,338 | $15,745 |
| Xtandi | 29 | $431,580 | $14,882 |
| Lenvima | 22 | $365,830 | $16,629 |
| Tagrisso | 17 | $302,145 | $17,773 |
| Jakafi | 16 | $287,160 | $17,948 |
| Lynparza | 28 | $228,923 | $8,176 |
| Erleada | 17 | $224,747 | $13,220 |
| Cabometyx | 15 | $186,639 | $12,443 |
| Eliquis | 125 | $95,933 | $767 |
| Xarelto | 67 | $73,917 | $1,103 |
| Gleevec | 11 | $60,113 | $5,465 |
| Abiraterone Acetate | 15 | $47,006 | $3,134 |
| Erlotinib | 18 | $40,824 | $2,268 |
| Oxycontin | 13 | $28,910 | $2,224 |
| Aromasin | 13 | $25,377 | $1,952 |
| Exemestane | 50 | $16,161 | $323 |
| Enoxaparin | 12 | $5,047 | $421 |
| Anastrozole | 115 | $4,100 | $36 |
| Imatinib Mesylate | 28 | $3,771 | $135 |
| Pantoprazole | 60 | $3,306 | $55 |
| Hydroxyurea | 31 | $1,851 | $60 |
| Ondansetron | 94 | $1,834 | $20 |
| Dexamethasone | 68 | $1,412 | $21 |
| Potassium Chloride | 61 | $1,333 | $22 |
| Oxycodone | 41 | $1,225 | $30 |
| Hydrocodone-Acetaminophen | 54 | $1,199 | $22 |
| Lorazepam | 105 | $1,088 | $10 |
| Tamoxifen Citrate | 18 | $1,053 | $58 |
| Hydromorphone | 27 | $750 | $28 |
| Letrozole | 13 | $745 | $57 |
| Levothyroxine | 50 | $707 | $14 |
| Diphenoxylate-Atropine | 34 | $678 | $20 |
| Methadone | 32 | $599 | $19 |
| Dutasteride | 14 | $479 | $34 |
| Metoprolol | 24 | $466 | $19 |
| Zolpidem | 69 | $440 | $6 |
| Rosuvastatin | 19 | $430 | $23 |
| Ondansetron Odt | 20 | $415 | $21 |
| Gabapentin | 50 | $405 | $8 |
| Acyclovir | 35 | $399 | $11 |
| Prednisone | 74 | $372 | $5 |
| Bicalutamide | 11 | $326 | $30 |
| Nystatin | 15 | $296 | $20 |
| Metoclopramide | 47 | $265 | $6 |
| Omeprazole | 18 | $253 | $14 |
| Tamsulosin | 16 | $252 | $16 |
| Furosemide | 35 | $237 | $7 |
| Trazodone | 11 | $232 | $21 |
| Duloxetine | 13 | $185 | $14 |
| Atorvastatin | 22 | $184 | $8 |
| Lisinopril | 18 | $184 | $10 |
| Diclofenac | 11 | $182 | $17 |
| Amoxicillin-Clavulanate Potass | 17 | $178 | $10 |
| Diazepam | 16 | $146 | $9 |
| Temazepam | 14 | $142 | $10 |
| Metformin | 17 | $137 | $8 |
| Promethazine | 12 | $131 | $11 |
| Paxlovid (Eua) | 13 | $130 | $10 |
| Alprazolam | 21 | $114 | $5 |
| Allopurinol | 16 | $105 | $7 |
| Amlodipine Besylate | 18 | $97 | $5 |
| Famotidine | 17 | $91 | $5 |
| Triamcinolone Acetonide | 11 | $83 | $8 |
| Ciprofloxacin | 13 | $70 | $5 |
| Tramadol | 13 | $65 | $5 |
| Folic Acid | 13 | $34 | $3 |
2022: 65 drugs
| Ibrance | 67 | $947,561 | $14,143 |
| Imbruvica | 44 | $540,886 | $12,293 |
| Tagrisso | 21 | $368,069 | $17,527 |
| Erleada | 23 | $330,897 | $14,387 |
| Cabometyx | 12 | $278,344 | $23,195 |
| Iclusig | 13 | $270,436 | $20,803 |
| Xtandi | 19 | $264,655 | $13,929 |
| Lenvima | 11 | $212,794 | $19,345 |
| Lynparza | 14 | $143,483 | $10,249 |
| Eliquis | 113 | $81,522 | $721 |
| Xarelto | 52 | $56,017 | $1,077 |
| Forteo | 12 | $50,848 | $4,237 |
| Imatinib Mesylate | 27 | $29,525 | $1,094 |
| Oxycontin | 11 | $26,039 | $2,367 |
| Exemestane | 55 | $20,444 | $372 |
| Megestrol Acetate | 18 | $4,866 | $270 |
| Anastrozole | 114 | $2,963 | $26 |
| Hydrocodone-Acetaminophen | 79 | $1,889 | $24 |
| Ondansetron | 82 | $1,756 | $21 |
| Dexamethasone | 79 | $1,748 | $22 |
| Potassium Chloride | 47 | $1,280 | $27 |
| Pantoprazole | 44 | $1,102 | $25 |
| Lorazepam | 94 | $1,089 | $12 |
| Hydromorphone | 46 | $1,041 | $23 |
| Rosuvastatin | 18 | $1,035 | $58 |
| Hydroxyurea | 26 | $865 | $33 |
| Bicalutamide | 11 | $842 | $77 |
| Levothyroxine | 50 | $774 | $15 |
| Methadone | 35 | $734 | $21 |
| Triamcinolone Acetonide | 19 | $690 | $36 |
| Gabapentin | 69 | $623 | $9 |
| Diphenoxylate-Atropine | 20 | $572 | $29 |
| Tamoxifen Citrate | 12 | $551 | $46 |
| Dutasteride | 17 | $548 | $32 |
| Oxycodone | 22 | $487 | $22 |
| Acyclovir | 33 | $467 | $14 |
| Nystatin | 19 | $435 | $23 |
| Zolpidem | 44 | $386 | $9 |
| Clonazepam | 15 | $315 | $21 |
| Atorvastatin | 24 | $305 | $13 |
| Metformin | 21 | $303 | $14 |
| Promethazine | 18 | $288 | $16 |
| Valacyclovir | 12 | $279 | $23 |
| Tamsulosin | 22 | $269 | $12 |
| Minocycline | 11 | $249 | $23 |
| Famotidine | 15 | $241 | $16 |
| Metoclopramide | 56 | $237 | $4 |
| Sertraline | 21 | $218 | $10 |
| Letrozole | 13 | $217 | $17 |
| Duloxetine | 13 | $213 | $16 |
| Temazepam | 12 | $199 | $17 |
| Prednisone | 43 | $185 | $4 |
| Metoprolol | 11 | $160 | $15 |
| Omeprazole | 14 | $149 | $11 |
| Amoxicillin-Clavulanate Potass | 16 | $133 | $8 |
| Paxlovid (Eua) | 12 | $127 | $11 |
| Amlodipine Besylate | 25 | $124 | $5 |
| Cephalexin | 18 | $112 | $6 |
| Ciprofloxacin | 16 | $110 | $7 |
| Trazodone | 25 | $96 | $4 |
| Ibuprofen | 17 | $88 | $5 |
| Azithromycin | 19 | $78 | $4 |
| Tramadol | 16 | $66 | $4 |
| Alprazolam | 13 | $58 | $4 |
| Citalopram Hbr | 17 | $58 | $3 |
2021: 55 drugs
| Ibrance | 48 | $645,706 | $13,452 |
| Erleada | 35 | $433,075 | $12,374 |
| Imbruvica | 40 | $410,874 | $10,272 |
| Afinitor | 12 | $201,309 | $16,776 |
| Venclexta | 16 | $168,075 | $10,505 |
| Eliquis | 57 | $47,288 | $830 |
| Xarelto | 39 | $38,662 | $991 |
| Imatinib Mesylate | 18 | $27,489 | $1,527 |
| Oxycontin | 15 | $27,261 | $1,817 |
| Exemestane | 75 | $16,611 | $221 |
| Bicalutamide | 25 | $2,707 | $108 |
| Hydrocodone-Acetaminophen | 81 | $2,458 | $30 |
| Anastrozole | 98 | $2,369 | $24 |
| Ondansetron | 84 | $1,919 | $23 |
| Hydroxyurea | 29 | $1,372 | $47 |
| Dutasteride | 16 | $1,290 | $81 |
| Potassium Chloride | 36 | $1,178 | $33 |
| Lorazepam | 97 | $1,023 | $11 |
| Temazepam | 21 | $938 | $45 |
| Levothyroxine | 44 | $917 | $21 |
| Hydromorphone | 32 | $851 | $27 |
| Methadone | 40 | $801 | $20 |
| Megestrol Acetate | 11 | $768 | $70 |
| Gabapentin | 52 | $720 | $14 |
| Tamoxifen Citrate | 16 | $711 | $44 |
| Oxycodone | 32 | $645 | $20 |
| Acyclovir | 21 | $628 | $30 |
| Pantoprazole | 35 | $626 | $18 |
| Dexamethasone | 33 | $617 | $19 |
| Letrozole | 24 | $527 | $22 |
| Fluconazole | 12 | $465 | $39 |
| Triamcinolone Acetonide | 26 | $389 | $15 |
| Loperamide | 12 | $251 | $21 |
| Sertraline | 20 | $246 | $12 |
| Tamsulosin | 18 | $235 | $13 |
| Prednisone | 35 | $232 | $7 |
| Baclofen | 14 | $213 | $15 |
| Nystatin | 20 | $197 | $10 |
| Zolpidem | 39 | $157 | $4 |
| Promethazine | 26 | $157 | $6 |
| Metformin | 18 | $151 | $8 |
| Metoclopramide | 35 | $150 | $4 |
| Citalopram Hbr | 23 | $130 | $6 |
| Losartan | 15 | $129 | $9 |
| Amoxicillin-Clavulanate Potass | 13 | $126 | $10 |
| Cephalexin | 19 | $122 | $6 |
| Trazodone | 22 | $110 | $5 |
| Tramadol | 18 | $109 | $6 |
| Atorvastatin | 16 | $100 | $6 |
| Ciprofloxacin | 17 | $94 | $6 |
| Amlodipine Besylate | 15 | $84 | $6 |
| Ibuprofen | 14 | $63 | $5 |
| Metoprolol | 11 | $52 | $5 |
| Furosemide | 17 | $38 | $2 |
| Alprazolam | 12 | $37 | $3 |
2020: 47 drugs
| Erleada | 40 | $500,892 | $12,522 |
| Imbruvica | 28 | $324,273 | $11,581 |
| Ibrance | 21 | $270,184 | $12,866 |
| Kisqali | 13 | $169,415 | $13,032 |
| Eliquis | 28 | $26,464 | $945 |
| Xarelto | 38 | $26,258 | $691 |
| Oxycontin | 12 | $23,160 | $1,930 |
| Exemestane | 57 | $16,333 | $287 |
| Leukeran | 12 | $8,609 | $717 |
| Anastrozole | 94 | $2,817 | $30 |
| Hydrocodone-Acetaminophen | 86 | $2,128 | $25 |
| Bicalutamide | 14 | $2,124 | $152 |
| Ondansetron | 88 | $1,984 | $23 |
| Potassium Chloride | 40 | $1,377 | $34 |
| Dutasteride | 13 | $1,377 | $106 |
| Dexamethasone | 40 | $989 | $25 |
| Hydromorphone | 35 | $981 | $28 |
| Oxycodone | 40 | $931 | $23 |
| Hydroxyurea | 14 | $908 | $65 |
| Clindamycin Phosphate | 19 | $860 | $45 |
| Lorazepam | 86 | $826 | $10 |
| Levothyroxine | 41 | $799 | $19 |
| Temazepam | 25 | $722 | $29 |
| Pantoprazole | 29 | $682 | $24 |
| Methadone | 28 | $592 | $21 |
| Gabapentin | 40 | $579 | $14 |
| Letrozole | 14 | $563 | $40 |
| Tamoxifen Citrate | 11 | $442 | $40 |
| Oxycodone-Acetaminophen | 14 | $404 | $29 |
| Megestrol Acetate | 11 | $392 | $36 |
| Acyclovir | 26 | $364 | $14 |
| Prednisone | 49 | $324 | $7 |
| Atorvastatin | 17 | $278 | $16 |
| Nystatin | 15 | $272 | $18 |
| Zolpidem | 39 | $251 | $6 |
| Furosemide | 11 | $229 | $21 |
| Tamsulosin | 11 | $226 | $21 |
| Butalbital-Acetaminophen-Caffe | 11 | $212 | $19 |
| Sertraline | 14 | $199 | $14 |
| Losartan | 22 | $180 | $8 |
| Azithromycin | 22 | $176 | $8 |
| Metoclopramide | 20 | $134 | $7 |
| Amoxicillin-Clavulanate Potass | 13 | $115 | $9 |
| Citalopram Hbr | 15 | $106 | $7 |
| Metformin | 21 | $103 | $5 |
| Cephalexin | 19 | $73 | $4 |
| Tramadol | 19 | $60 | $3 |
2019: 42 drugs
| Imbruvica | 41 | $285,572 | $6,965 |
| Erleada | 19 | $232,256 | $12,224 |
| Ibrance | 16 | $197,796 | $12,362 |
| Tarceva | 13 | $84,447 | $6,496 |
| Venclexta | 11 | $83,718 | $7,611 |
| Xarelto | 53 | $31,466 | $594 |
| Eliquis | 37 | $20,036 | $542 |
| Oxycontin | 12 | $18,570 | $1,547 |
| Exemestane | 44 | $11,928 | $271 |
| Potassium Chloride | 53 | $5,097 | $96 |
| Anastrozole | 64 | $1,721 | $27 |
| Hydrocodone-Acetaminophen | 64 | $1,664 | $26 |
| Ondansetron | 119 | $1,645 | $14 |
| Dutasteride | 15 | $1,596 | $106 |
| Hydromorphone | 52 | $1,476 | $28 |
| Dexamethasone | 53 | $1,167 | $22 |
| Hydroxyurea | 15 | $1,036 | $69 |
| Temazepam | 43 | $1,033 | $24 |
| Oxycodone | 36 | $919 | $26 |
| Gabapentin | 33 | $912 | $28 |
| Diphenoxylate-Atropine | 16 | $741 | $46 |
| Lorazepam | 76 | $664 | $9 |
| Levothyroxine | 31 | $533 | $17 |
| Prednisone | 65 | $511 | $8 |
| Methadone | 24 | $369 | $15 |
| Acyclovir | 23 | $358 | $16 |
| Ondansetron Odt | 13 | $251 | $19 |
| Metformin | 26 | $231 | $9 |
| Pantoprazole | 27 | $224 | $8 |
| Omeprazole | 15 | $215 | $14 |
| Furosemide | 11 | $174 | $16 |
| Metoclopramide | 32 | $172 | $5 |
| Zolpidem | 27 | $166 | $6 |
| Diazepam | 12 | $150 | $13 |
| Metformin Hcl Er | 12 | $143 | $12 |
| Ciprofloxacin | 11 | $99 | $9 |
| Azithromycin | 13 | $96 | $7 |
| Tramadol | 21 | $91 | $4 |
| Hydrochlorothiazide | 13 | $72 | $6 |
| Lisinopril | 15 | $54 | $4 |
| Amlodipine Besylate | 13 | $45 | $3 |
| Alprazolam | 12 | $36 | $3 |
2018: 38 drugs
| Zytiga | 19 | $198,404 | $10,442 |
| Ibrance | 15 | $165,140 | $11,009 |
| Tarceva | 20 | $139,091 | $6,955 |
| Xtandi | 11 | $119,469 | $10,861 |
| Xarelto | 36 | $19,118 | $531 |
| Exemestane | 20 | $7,136 | $357 |
| Eliquis | 12 | $5,727 | $477 |
| Potassium Chloride | 43 | $4,623 | $108 |
| Dutasteride | 15 | $1,976 | $132 |
| Diphenoxylate-Atropine | 29 | $1,563 | $54 |
| Anastrozole | 68 | $1,462 | $21 |
| Hydromorphone | 40 | $1,359 | $34 |
| Clobetasol Propionate | 15 | $1,131 | $75 |
| Oxycodone | 43 | $1,085 | $25 |
| Ondansetron | 80 | $1,012 | $13 |
| Hydroxyurea | 15 | $893 | $60 |
| Hydrocodone-Acetaminophen | 50 | $846 | $17 |
| Dexamethasone | 31 | $842 | $27 |
| Levothyroxine | 42 | $791 | $19 |
| Gabapentin | 30 | $716 | $24 |
| Lorazepam | 83 | $596 | $7 |
| Acyclovir | 13 | $568 | $44 |
| Prednisone | 44 | $337 | $8 |
| Zolpidem | 31 | $244 | $8 |
| Sertraline | 19 | $212 | $11 |
| Pantoprazole | 24 | $211 | $9 |
| Diazepam | 17 | $199 | $12 |
| Temazepam | 38 | $196 | $5 |
| Metformin | 15 | $156 | $10 |
| Metoclopramide | 30 | $146 | $5 |
| Amoxicillin-Clavulanate Potass | 18 | $138 | $8 |
| Azithromycin | 17 | $122 | $7 |
| Eszopiclone | 13 | $110 | $8 |
| Tramadol | 17 | $93 | $5 |
| Ciprofloxacin | 11 | $89 | $8 |
| Amlodipine Besylate | 13 | $58 | $4 |
| Lisinopril | 17 | $29 | $2 |
| Alprazolam | 12 | $25 | $2 |
2017: 34 drugs
| Ibrance | 34 | $382,862 | $11,261 |
| Tarceva | 37 | $267,708 | $7,235 |
| Imatinib Mesylate | 19 | $112,267 | $5,909 |
| Xtandi | 13 | $103,736 | $7,980 |
| Xarelto | 24 | $9,982 | $416 |
| Lyrica | 11 | $4,455 | $405 |
| Clobetasol Propionate | 19 | $2,654 | $140 |
| Diphenoxylate-Atropine | 22 | $1,084 | $49 |
| Levothyroxine | 51 | $1,030 | $20 |
| Hydromorphone | 45 | $1,000 | $22 |
| Oxycodone | 30 | $823 | $27 |
| Tamoxifen Citrate | 16 | $809 | $51 |
| Hydrocodone-Acetaminophen | 38 | $664 | $17 |
| Potassium Chloride | 24 | $647 | $27 |
| Ondansetron | 44 | $613 | $14 |
| Ondansetron Odt | 25 | $610 | $24 |
| Nystatin | 26 | $556 | $21 |
| Acyclovir | 14 | $537 | $38 |
| Duloxetine | 20 | $509 | $25 |
| Anastrozole | 46 | $413 | $9 |
| Gabapentin | 15 | $362 | $24 |
| Lorazepam | 58 | $335 | $6 |
| Pantoprazole | 24 | $295 | $12 |
| Temazepam | 38 | $246 | $6 |
| Dexamethasone | 31 | $226 | $7 |
| Prednisone | 28 | $213 | $8 |
| Metoclopramide | 40 | $168 | $4 |
| Methylprednisolone | 11 | $131 | $12 |
| Sertraline | 14 | $130 | $9 |
| Zolpidem | 22 | $119 | $5 |
| Azithromycin | 16 | $112 | $7 |
| Amoxicillin-Clavulanate Potass | 12 | $95 | $8 |
| Ciprofloxacin | 12 | $79 | $7 |
| Furosemide | 16 | $64 | $4 |
2016: 38 drugs
| Xtandi | 27 | $233,742 | $8,657 |
| Tarceva | 33 | $215,716 | $6,537 |
| Ibrance | 20 | $208,911 | $10,446 |
| Imbruvica | 16 | $152,502 | $9,531 |
| Neulasta | 13 | $109,635 | $8,433 |
| Oxycontin | 25 | $25,632 | $1,025 |
| Xarelto | 26 | $13,966 | $537 |
| Exemestane | 25 | $5,380 | $215 |
| Lidocaine | 11 | $2,072 | $188 |
| Clobetasol Propionate | 14 | $1,970 | $141 |
| Hydrocodone-Acetaminophen | 53 | $1,808 | $34 |
| Hydromorphone | 40 | $1,722 | $43 |
| Oxycodone | 32 | $988 | $31 |
| Doxycycline Hyclate | 17 | $857 | $50 |
| Diphenoxylate-Atropine | 11 | $847 | $77 |
| Potassium Chloride | 37 | $711 | $19 |
| Lorazepam | 77 | $666 | $9 |
| Duloxetine | 21 | $614 | $29 |
| Ondansetron | 44 | $539 | $12 |
| Nystatin | 24 | $539 | $22 |
| Anastrozole | 47 | $511 | $11 |
| Ondansetron Odt | 28 | $480 | $17 |
| Temazepam | 36 | $407 | $11 |
| Levothyroxine | 22 | $367 | $17 |
| Gabapentin | 21 | $298 | $14 |
| Amoxicillin-Clavulanate Potass | 16 | $291 | $18 |
| Dexamethasone | 31 | $243 | $8 |
| Zolpidem | 11 | $196 | $18 |
| Triamcinolone Acetonide | 13 | $177 | $14 |
| Pantoprazole | 15 | $168 | $11 |
| Letrozole | 13 | $167 | $13 |
| Metoclopramide | 40 | $161 | $4 |
| Prednisone | 19 | $154 | $8 |
| Amlodipine Besylate | 15 | $128 | $9 |
| Azithromycin | 19 | $123 | $6 |
| Lisinopril | 15 | $120 | $8 |
| Ciprofloxacin | 14 | $118 | $8 |
| Furosemide | 15 | $111 | $7 |
2015: 30 drugs
| Oxycontin | 31 | $23,121 | $746 |
| Exemestane | 36 | $11,172 | $310 |
| Xarelto | 25 | $9,373 | $375 |
| Dexamethasone | 37 | $2,516 | $68 |
| Hydrocodone-Acetaminophen | 40 | $1,477 | $37 |
| Morphine Sulfate Er | 12 | $1,295 | $108 |
| Ondansetron | 60 | $1,223 | $20 |
| Doxycycline Hyclate | 18 | $1,147 | $64 |
| Hydromorphone | 22 | $950 | $43 |
| Oxycodone | 27 | $928 | $34 |
| Duloxetine | 14 | $746 | $53 |
| Anastrozole | 46 | $722 | $16 |
| Potassium Chloride | 42 | $589 | $14 |
| Tamoxifen Citrate | 12 | $558 | $46 |
| Lorazepam | 71 | $539 | $8 |
| Temazepam | 39 | $372 | $10 |
| Acyclovir | 13 | $328 | $25 |
| Amoxicillin-Clavulanate Potass | 14 | $245 | $17 |
| Levothyroxine | 14 | $224 | $16 |
| Pantoprazole | 28 | $211 | $8 |
| Amlodipine Besylate | 16 | $127 | $8 |
| Prednisone | 14 | $116 | $8 |
| Alprazolam | 17 | $112 | $7 |
| Ciprofloxacin | 14 | $110 | $8 |
| Furosemide | 20 | $105 | $5 |
| Gabapentin | 13 | $98 | $8 |
| Zolpidem | 12 | $93 | $8 |
| Lisinopril | 12 | $80 | $7 |
| Cephalexin | 13 | $70 | $5 |
| Metoclopramide | 15 | $56 | $4 |
2014: 23 drugs
| Exemestane | 39 | $7,644 | $196 |
| Xarelto | 16 | $4,831 | $302 |
| Dexamethasone | 49 | $3,666 | $75 |
| Potassium Chloride | 36 | $1,265 | $35 |
| Anastrozole | 53 | $1,190 | $22 |
| Ondansetron | 50 | $874 | $17 |
| Amox Tr-Potassium Clavulanate | 16 | $534 | $33 |
| Tamoxifen Citrate | 23 | $530 | $23 |
| Hydrocodone-Acetaminophen | 20 | $525 | $26 |
| Nadolol | 12 | $425 | $35 |
| Gabapentin | 22 | $180 | $8 |
| Lorazepam | 18 | $174 | $10 |
| Azithromycin | 16 | $121 | $8 |
| Zolpidem | 24 | $106 | $4 |
| Metoclopramide | 26 | $105 | $4 |
| Pantoprazole | 14 | $99 | $7 |
| Omeprazole | 12 | $94 | $8 |
| Temazepam | 15 | $87 | $6 |
| Fluoxetine | 11 | $86 | $8 |
| Furosemide | 19 | $82 | $4 |
| Alprazolam | 12 | $47 | $4 |
| Lisinopril | 12 | $39 | $3 |
| Hydrochlorothiazide | 12 | $6 | $1 |
2013: 21 drugs
| Emend | 17 | $10,528 | $619 |
| Exemestane | 17 | $5,827 | $343 |
| Dexamethasone | 58 | $2,082 | $36 |
| Anastrozole | 60 | $2,078 | $35 |
| Hydrocodone-Acetaminophen | 39 | $1,514 | $39 |
| Potassium Chloride | 20 | $931 | $47 |
| Ondansetron | 40 | $661 | $17 |
| Nystatin | 11 | $394 | $36 |
| Nadolol | 12 | $370 | $31 |
| Tamoxifen Citrate | 19 | $245 | $13 |
| Prednisone | 37 | $206 | $6 |
| Omeprazole | 12 | $179 | $15 |
| Diphenoxylate-Atropine | 14 | $171 | $12 |
| Lorazepam | 19 | $169 | $9 |
| Zolpidem | 26 | $162 | $6 |
| Metoclopramide | 32 | $153 | $5 |
| Temazepam | 18 | $150 | $8 |
| Tramadol | 13 | $147 | $11 |
| Alendronate | 13 | $97 | $7 |
| Alprazolam | 14 | $76 | $5 |
| Lisinopril | 16 | $51 | $3 |
Money from drug and device companies
$25 in 2023
| 2023 | 1 | 1 | None | $25 |
| 2021 | 2 | 2 | None | $31 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Ibrance | $25 | 1 payment
|
See the published payment
| Pfizer | Education · 2023-07-27 | Ibrance | $25 |
See earlier years (2021)
2021: $31
| Pharmacyclics LLC An AbbVie | Imbruvica | $19 | 1 payment
|
| Gilead Sciences | None | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1497076467
- Licence
- CA 16415California A16415: Cancelled
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X); Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-06-14
- NPI last updated
- 2025-12-30
- NPI record certified
- 2025-12-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2490 Hospital Dr Ste 111, Mountain View, CA, 94040